June 15, 2020 – Vancouver, BC – Geyser Brands Inc. (TSX-V: GYSR) (“Geyser Brands” or the “Company”) is pleased to announce that the Company's subsidiary, 0957102 B.C. Ltd. DBA Apothecary Botanicals ("Apothecary Botanicals"), has been awarded by Health Canada its full sales license.
With the awarded licenses, Geyser Brands will manufacture, distribute and sell Cannabis containing topicals, edibles, and beverages related directly to medical patients and to provincial distributors across Canada. In anticipation of these licenses, the Company has already developed and registered with Health Canada a portfolio of Cannabis 2.0 products, including teas and coffees, tinctures, sprays and extracts, and chocolates and gummies.
The Company's most immediate focus is in topicals, where it is has manufacturing capacity to produce gels and creams in tubes, roll-on containers and jars. Its first product is a CBD/THC roll-on gel intended for the pain relief market, and which it will start delivering in the second half of June. These products will be manufactured for Geyser portfolio brands such as Apothecary Labs, and for 3rd party white labels.
Kuldip Gill, Chief Operating Officer at Apothecary Botanicals, commented, "We are thrilled to announce that we have been awarded our remaining Sales Licenses from Health Canada. We now have the opportunity to connect our products and manufacturing more directly to consumers. We look forward to working with some of our existing and new partners to extend their product ranges through our manufacturing, and to monetizing their customer base through our new distribution capability."
ABOUT GEYSER BRANDS
Geyser Brands Inc. develops consumer product brands in the health and wellness sector that use hemp and CBD as a value-added ingredient. These involve next-generation formulas that focus on the mix of cannabinoids for specific conditions such as insomnia, anxiety and pain. Proprietary delivery technologies include all natural nano-technology, slow-release mechanisms and non-molecule degrading baking processes. In anticipation of coming edibles legislation, and with its Health Canada approved Licensed Production Facility, Geyser Brands has 15,000 square feet in two GMP facilities in Vancouver, BC.
For more information, visit the company’s website at www.geyserbrands.com.
On Behalf of the Board of Directors
Director and CEO